Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families

American Journal of Human Genetics

Volumn 62, Issue 3, 1998, Pages 676-689

  Ford, D ^a   Easton, D F ^b,z   Stratton, M ^a   Narod, S ^d   Goldgar, D ^e   Devilee, P ^f   Bishop, D T ^g   Weber, B ^h   Lenoir, G ^e   Chang Claude, J ⁱ   Sobol, H ^j   Teare, M D ^b   Struewing, J ^k   Arason, A ^l   Scherneck, S ⁿ   Peto, J ^a   Rebbeck, T R ^h   Tonin, P ^o   Neuhausen, S ^p   Barkardottir, R ^l   Eyfjord, J ^m   Lynch, H ^q   Ponder, B A J ^c   Gayther, S A ^c   Birch, J M ^r   Lindblom, A ^s   Stoppa Lyonnet, D ^t   Bignon, Y ^u   Borg, A ^v   Hamann, U ⁱ   Haites, N ^w   Scott, R J ^x   Maugard, C M ^y   Vasen, H ^y   Seitz, S ⁿ   Cannon Albright, L A ^p   Schofield, A ^w   Zelada Hedman, M ^s   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f LEIDEN UNIVERSITY   (Netherlands)

^g IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j INSTITUT PAOLI CALMETTES   (France)

^k NATIONAL CANCER INSTITUTE   (United States)

^l LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^m ICELANDIC CANCER SOCIETY   (Iceland)

ⁿ MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^o MCGILL UNIVERSITY   (Canada)

^p UNIVERSITY OF UTAH   (United States)

^q CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r CHRISTIE HOSPITAL   (United Kingdom)

^s KAROLINSKA INSTITUTE   (Sweden)

^t INSTITUT CURIE   (France)

^u CENTRE JEAN PERRIN   (France)

^v LUND UNIVERSITY HOSPITAL   (Sweden)

^w UNIVERSITY HOSPITAL BASEL   (Switzerland)

^x CENTRE RENÉ GAUDUCHEAU   (France)

^y Strangeways Research Laboratories ^*

^z UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER FAMILY; GENETIC HETEROGENEITY; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PENETRANCE; PRIORITY JOURNAL;

EID: 17344365851     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301749     Document Type: Article

References (39)

1. Bowcock AM, Anderson LA, Friedman LS, Black DM, Osborne-Lawrence S, Rowell SE, Hall JM, et al (1993) THRA1 and D17S183 flank an interval of <4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am J Hum Genet 52:718-722
2. Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232-242
3. Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1993) Analysis of the genetic relationship between breast and ovarian cancer. Am J Hum Genet Suppl 53:787
4. Cottingham RW Jr, Idury RM, Schäffer AA (1993) Faster sequential genetic linkage computations. Am J Hum Genet 53: 252-263
5. Easton DF, Bishop DT, Ford D, Crockford GP, Breast Cancer Linkage Consortium (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52:678-701
6. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271
7. Easton DF, Steele L, Fields P, Ormiston W, Averill D, Daly PA, McManus R, et al (1997) Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 61:120-128
8. EIston RC (1995) 'Twixt cup and lip: how intractable is the ascertainment problem? Am J Hum Genet 56:15-17
9. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCA1 mutation carriers. Lancet 343:692-695
10. Ganguly A, Rock MJ, Prockop DJ (1993) Confirmation sensitive gel electrophoresis for rapid detection of single base differences in double stranded PCR products and DNA fragments - evidence for solvent induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 90:10325-10329
11. Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BAJ (1996) Rpaid detection of regionally clustered germ-line BRCA1 mutations by multiple heteroduplex analysis. Am J Hum Genet 58:451-456
12. Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BAJ, Stratton MR, et al (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15:103-105
13. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, et al (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 11:428-433
14. Gyapay G, Morissette J, Vignal A, Dib C, Fizomes C, Millasseau P, Marc S, et al (1994) The 1993-94 Généthon human genetic linkage map. Nat Genet 7:246-339
15. Håkansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes A-M, Holmberg E, et al (1997) Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 60: 1068-1078
16. Hall JM, Friedman L, Guenther C, Lee MK, Weber JL, Black DM, King M-C (1992) Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 50:1235-1242
17. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689
18. Hemmenki A, Tomlinson I, Markie D, Jarvinen H, Sistonen P, Bjorkqvist AM, Knuutila S, et al (1997) Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 15:87-90
19. Hogervorst FBL, Cornelis RS, Baut M, van Vliet M, Oosterwijk JC, Olmer R, Bakker B, et al (1995) Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 10:208-212
20. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King M-C, Jenson RA (1996) Growth retardation and tumour inhibition. Nat Genet 12:298-302
21. Kerangueven F, Essioux L, Dib A, Noguchi T, Allione F, Geneix J, Longy M, et al (1995) Loss of heterozygosity and linkage analysis in breast-carcinoma - indication for a putative 3rd susceptibility gene on the short arm of chromosome 8. Oncogene 10:1023-1026
22. Lathrop GM, Lalouel JM, Julier C, Ott J (1984) Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81:3443-3446
23. Liaw D, Marsh D, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, et al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67
24. Miki Y, Swensen J, Schattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu QY, et al (1994) Isolation of BRCA1, the 17q-linked breast and ovarian cancer susceptibility gene. Science 266:66-71
25. Narod SA, Ford D, Devilee P, Barkardottir RB, Eyfjord J, Lenoir G, Serova O, et al (1995a) Genetic heterogeneity of breast-ovarian cancer revisited. Am J Hum Genet 57:957
26. Narod S, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BAJ, et al (1995b) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 56:254-264
27. Peelen T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AMW (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60:1041-1049
28. Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirlan P, et al (1996) Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet 13:120-122
29. Schubert EL, Lee MK, Mefford HC, Argonza RH, Morrow JE, Hull J, Dann JL, et al (1997) BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet 60: 1031-1040
30. Seitz S, Rohde K, Bender E, Nothnagel A, Kolble K, Schlag PM, Scherneck S (1997) Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families. Oncogene 14: 741-743
31. Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar D, et al (1997) Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet 60:486-495
32. Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pages S, Ithier G, Ligot L, Fourquet A, et al (1997) BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Am J Hum Genet 60:1021-1030
33. Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, King MC, et al (1994) Familial male breast cancer is not linked to BRCA1. Nat Genet 7:103-107
34. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408
35. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, et al (1996) The complete BRCA2 gene and mutations in 13q-linked kindreds. Nat Genet 12:333-337
36. Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldson H (1992) Risk of prostate, ovarian and endometrial cancer among relatives of women with breast cancer. Br Med J 305: 855-857
37. Weber JM, Kwitek AE, May PE, Wallace MS, Collins FS, Ledbetter DH (1990) Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res 18:464
38. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792
39. Wooster R, Neuhausen S, Manigion J, Quirk Y, Ford D, Collins N, Nguyen K, et al (1994) Localisation of a breast cancer susceptibility gene (BRCA2) to chromosome 13q by genetic linkage analysis. Science 265: 2088-2090